Updated Jul 16, 2026
Wolf Myles has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Wolf Myles is referenced in SEC filings related to Akebia Therapeutics, Inc. as of June 22, 2026. Publicly available filings do not reveal detailed biographical information or a clearly defined current role beyond the association indicated in the filings. There are no widely reported profiles or obituaries for this exact name in major business information sources as of the date of this response.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | AKBA | Akebia Therapeutics, Inc. | A — Grant or award | 35.7K | $0.00 |
Wolf Myles is referenced in SEC filings related to Akebia Therapeutics, Inc. as of June 22, 2026. Publicly available filings do not reveal detailed biographical information or a clearly defined current role beyond the association indicated in the filings. There are no widely reported profiles or obituaries for this exact name in major business information sources as of the date…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wolf Myles profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.